• 23933 Citations
19982023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Management of breast cancer with particular focus on inflammatory breast cancer (IBC), Locally Advanced Breast Cancer (LABC) and Metastatic Breast Cancer (MBC). Expertise in new endocrine therapies for hormone-receptor positive MBC.

Novel biomarkers of endocrine resistance in breast cancer. Circulating tumor cells (CTCs) and ctDNA. Drug development with focus on endocrine therapy.

Training Experience

1994Internship, Cabrini Medical Center, New York, NY
1996Residency, Cabrini Medical Center, New York, NY
1998Fellowship, University of Texas/MD Anderson Cancer Center

Education/Academic qualification

MD, University La Sapienza, Rome, Italy

… → 1986

Keywords

  • Breast Cancer
  • Cancer Genetics
  • Chemotherapy
  • Molecular Diagnostics
  • Oncology

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Inflammatory Breast Neoplasms Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2015 2023

Triple Negative Breast Neoplasms
Phosphotransferases
Neoplasms
Therapeutics
T-Lymphocytes
Neutrophils
Breast Neoplasms
Neoplasm Metastasis
zileuton
T-Lymphocytes

Research Output 1998 2019

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA

Ye, Z., Wang, C., Wan, S., Mu, Z., Zhang, Z., Abu-Khalaf, M. M., Fellin, F. M., Silver, D. P., Neupane, M., Jaslow, R. J., Bhattacharya, S., Tsangaris, T. N., Chervoneva, I., Berger, A., Austin, L., Palazzo, J. P., Myers, R. E., Pancholy, N., Toorkey, D., Yao, K. & 10 othersKrall, M., Li, X., Chen, X., Fu, X., Xing, J., Hou, L., Wei, Q., Li, B., Cristofanilli, M. & Yang, H., Jan 1 2019, In : European Journal of Cancer. 106, p. 133-143 11 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Breast Neoplasms
DNA
Disease-Free Survival
Survival

Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer

Mego, M., Karaba, M., Minarik, G., Benca, J., Silvia, J., Sedlackova, T., Manasova, D., Kalavska, K., Pindak, D., Cristofanilli, M., Reuben, J. M. & Mardiak, J., Apr 1 2019, In : Anticancer research. 39, 4, p. 1829-1837 9 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Epithelial-Mesenchymal Transition
Breast Neoplasms
Phenotype
Disease-Free Survival

Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?

Buono, G., Gerratana, L., Bulfoni, M., Provinciali, N., Basile, D., Giuliano, M., Corvaja, C., Arpino, G., Del Mastro, L., De Placido, S., De Laurentiis, M., Cristofanilli, M. & Puglisi, F., Feb 1 2019, In : Cancer Treatment Reviews. 73, p. 73-83 11 p.

Research output: Contribution to journalReview article

Breast Neoplasms
DNA
Neoplasms
Biopsy
Precision Medicine
1 Citation (Scopus)

Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ERþ/HER2 mutant breast cancer

Croessmann, S., Formisano, L., Kinch, L. N., Gonzalez-Ericsson, P. I., Sudhan, D. R., Nagy, R. J., Mathew, A., Bernicker, E. H., Cristofanilli, M., He, J., Cutler, R. E., Lalani, A. S., Miller, V. A., Lanman, R. B., Grishin, N. V. & Arteaga, C. L., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 277-289 13 p.

Research output: Contribution to journalArticle

Estradiol Congeners
Estrogen Receptors
Breast Neoplasms
Mutation
MCF-7 Cells

Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer

Dogan, B. E., Yuan, Q., Bassett, R., Guvenc, I., Jackson, E. F., Cristofanilli, M. & Whitman, G. J., May 1 2019, In : Current Problems in Diagnostic Radiology. 48, 3, p. 235-240 6 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Magnetic Resonance Imaging
Breast Neoplasms
Drug Therapy
Survival